Repare Therapeutics (RPTX) Competitors $1.69 0.00 (0.00%) Closing price 09/5/2025 04:00 PM EasternExtended Trading$1.72 +0.03 (+1.48%) As of 09/5/2025 06:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock RPTX vs. FHTX, LFCR, TVRD, NMRA, GALT, DRUG, MREO, AVIR, DBVT, and NGNEShould you be buying Repare Therapeutics stock or one of its competitors? The main competitors of Repare Therapeutics include Foghorn Therapeutics (FHTX), Lifecore Biomedical (LFCR), Tvardi Therapeutics (TVRD), Neumora Therapeutics (NMRA), Galectin Therapeutics (GALT), Bright Minds Biosciences (DRUG), Mereo BioPharma Group (MREO), Atea Pharmaceuticals (AVIR), DBV Technologies (DBVT), and Neurogene (NGNE). These companies are all part of the "pharmaceutical products" industry. Repare Therapeutics vs. Its Competitors Foghorn Therapeutics Lifecore Biomedical Tvardi Therapeutics Neumora Therapeutics Galectin Therapeutics Bright Minds Biosciences Mereo BioPharma Group Atea Pharmaceuticals DBV Technologies Neurogene Repare Therapeutics (NASDAQ:RPTX) and Foghorn Therapeutics (NASDAQ:FHTX) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, profitability, earnings, dividends, media sentiment, valuation, risk and analyst recommendations. Which has more volatility & risk, RPTX or FHTX? Repare Therapeutics has a beta of 0.94, suggesting that its stock price is 6% less volatile than the S&P 500. Comparatively, Foghorn Therapeutics has a beta of 3.05, suggesting that its stock price is 205% more volatile than the S&P 500. Do analysts prefer RPTX or FHTX? Repare Therapeutics presently has a consensus target price of $4.50, indicating a potential upside of 166.27%. Foghorn Therapeutics has a consensus target price of $10.67, indicating a potential upside of 84.86%. Given Repare Therapeutics' higher possible upside, equities analysts plainly believe Repare Therapeutics is more favorable than Foghorn Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Repare Therapeutics 0 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.50Foghorn Therapeutics 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 2 Strong Buy rating(s) 3.17 Do institutionals and insiders believe in RPTX or FHTX? 85.1% of Repare Therapeutics shares are owned by institutional investors. Comparatively, 61.6% of Foghorn Therapeutics shares are owned by institutional investors. 11.5% of Repare Therapeutics shares are owned by company insiders. Comparatively, 7.6% of Foghorn Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Does the media refer more to RPTX or FHTX? In the previous week, Foghorn Therapeutics had 1 more articles in the media than Repare Therapeutics. MarketBeat recorded 3 mentions for Foghorn Therapeutics and 2 mentions for Repare Therapeutics. Repare Therapeutics' average media sentiment score of 1.64 beat Foghorn Therapeutics' score of 1.07 indicating that Repare Therapeutics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Repare Therapeutics 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Foghorn Therapeutics 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is RPTX or FHTX more profitable? Repare Therapeutics has a net margin of 0.00% compared to Foghorn Therapeutics' net margin of -311.90%. Foghorn Therapeutics' return on equity of 0.00% beat Repare Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Repare TherapeuticsN/A -78.25% -66.85% Foghorn Therapeutics -311.90%N/A -28.00% Which has higher earnings & valuation, RPTX or FHTX? Repare Therapeutics has higher revenue and earnings than Foghorn Therapeutics. Foghorn Therapeutics is trading at a lower price-to-earnings ratio than Repare Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRepare Therapeutics$53.48M1.36-$84.69M-$2.58-0.66Foghorn Therapeutics$22.60M14.43-$86.62M-$1.19-4.85 SummaryFoghorn Therapeutics beats Repare Therapeutics on 9 of the 17 factors compared between the two stocks. Get Repare Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for RPTX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding RPTX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RPTX vs. The Competition Export to ExcelMetricRepare TherapeuticsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$72.60M$3.12B$5.79B$9.92BDividend YieldN/A2.28%6.71%4.53%P/E Ratio-0.6621.1076.0826.13Price / Sales1.36229.57460.9379.98Price / CashN/A44.9736.9659.04Price / Book0.479.8711.486.09Net Income-$84.69M-$53.42M$3.29B$266.51M7 Day Performance1.20%2.93%1.27%0.45%1 Month Performance10.46%9.85%7.94%4.58%1 Year Performance-40.07%15.74%62.93%26.04% Repare Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RPTXRepare Therapeutics3.2678 of 5 stars$1.69flat$4.50+166.3%-38.5%$72.60M$53.48M-0.66180News CoveragePositive NewsFHTXFoghorn Therapeutics2.6854 of 5 stars$5.06+1.0%$10.67+110.8%-28.6%$286.04M$22.60M-4.25120Positive NewsLFCRLifecore Biomedical1.1309 of 5 stars$7.61-0.1%$8.00+5.1%+64.4%$284.67M$128.87M-5.81690Trending NewsAnalyst ForecastAnalyst RevisionTVRDTvardi TherapeuticsN/A$29.92-1.2%$64.25+114.7%N/A$280.57M$7.14M0.0080Positive NewsGap UpNMRANeumora Therapeutics3.1298 of 5 stars$1.73-1.7%$7.14+312.9%-84.4%$280.17MN/A-1.10108Short Interest ↓GALTGalectin Therapeutics1.8717 of 5 stars$4.28+0.7%$6.00+40.2%+88.5%$274.18MN/A-6.699News CoverageDRUGBright Minds Biosciences2.8364 of 5 stars$38.88-8.8%$83.25+114.1%+3,449.6%$273.91MN/A-41.81N/ANews CoverageMREOMereo BioPharma Group2.5842 of 5 stars$1.71-2.3%$7.40+332.7%-60.0%$271.89M$10M-24.4340Positive NewsAVIRAtea Pharmaceuticals2.3255 of 5 stars$3.36-3.2%$6.00+78.6%-6.9%$266.64MN/A-2.0970DBVTDBV Technologies2.8704 of 5 stars$9.58+0.8%$14.75+54.0%+125.5%$264.31M$4.15M-2.0180News CoverageGap DownNGNENeurogene2.4093 of 5 stars$18.48-1.9%$46.17+149.8%-42.0%$263.74M$930K-4.2990News CoveragePositive News Related Companies and Tools Related Companies Foghorn Therapeutics Alternatives Lifecore Biomedical Alternatives Tvardi Therapeutics Alternatives Neumora Therapeutics Alternatives Galectin Therapeutics Alternatives Bright Minds Biosciences Alternatives Mereo BioPharma Group Alternatives Atea Pharmaceuticals Alternatives DBV Technologies Alternatives Neurogene Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:RPTX) was last updated on 9/6/2025 by MarketBeat.com Staff From Our PartnersStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredOdd “310F trade” doubles investor’s money in just 3 days?Have you heard of 310F? This unusual trade setup has quietly delivered one of the most consistent profit st...Eagle Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe man running the U.S. dollar… is hoarding goldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredScientists Discover Untapped Energy Source in Heart of USACrash Coming Sept 30? Analysts Warn of New Crisis A new problem on the U.S. power grid is putting millions ...Altimetry | SponsoredWall Street Legend Names #1 ‘Hidden’ AI Stock50-year Wall Street legend says to forget NVDA. For the biggest potential gains, it's time to move your money ...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Repare Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Repare Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
